Heimdall Insights

Global Atypical Hemolytic Uremic Syndrome Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: August 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Atypical Hemolytic Uremic Syndrome Market was valued at $1.4 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 5.5% CAGR, to an estimated market size of $1.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The Atypical Hemolytic Uremic Syndrome (aHUS) market encompasses the diagnosis, management, and therapeutic treatment of a rare, life-threatening genetic disorder characterized by chronic, uncontrolled activation of the complement system, resulting in thrombotic microangiopathy (TMA), hemolytic anemia, and acute renal impairment.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Atypical Hemolytic Uremic Syndrome Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • C5 Inhibitors (Monoclonal Antibodies)
  • Next-Generation & Oral Therapies
  • Supportive Care & Plasma Therapy